Minocycline
AMZEEQ, Arestin, Minocin, ZILXI
Tetracycline-class Drug
NADAC/unit
$0.1748
No Shortage
Tier 1: 121.6%
11 Manufacturers
53 ANDAs
vs. brand AMZEEQ: Generic saves up to 98% per unit
Active Shortages
2025-05-23 Permanent discontinuation of manufacture due to business decision., Teva Pharmaceuticals USA, Inc.
Generic Manufacturers
ALKEM LABORATORIES LTDAUROBINDO PHARMA LTDBAUSCH HEALTH US LLCCHARTWELL RX SCIENCES LLCIMPAX LABORATORIES INCJOURNEY MEDICAL CORPORAPHARMA INCREGCON HOLDINGS LLCREMPEX PHARMACEUTICALS INC A WHOLLY OWNED SUB OF MELINTA THERAPEUTICS LLCSANDOZ INCSTRIDES PHARMA INTERNATIONAL AGTORRENT PHARMACEUTICALS LTDWATSON LABORATORIES INCWATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INCZYDUS WORLDWIDE DMCC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.